Research line

Genetics and genomics of neurodenerative diseases.


Identification of new genetic biomarkers and therapeutic targets for Amiotrophic Lateral Sclerosis (ALS), Parkinson and Alzheimer’s diseases, using next generation sequencing and RNAseq. Characterization of pharmacogenetics biomarkers in the response and safety of treatments for neurodegenerative diseases.



  • Disease / disorder characterization: Genomic characterization of patients samples by microarray and RNAseq technologies
  • Treatment discovery: Pharmacogenetics for response and safety of treatments
  • Methods for diagnostic: Genetic and genomic analysis
  • Clinical data: DNA samples and clinical data for ALS, Parkinson and Alzheimer disease
  • Development of new tools / technologies / computational methods: Bioinformatics for variant analysis and RNA expresión


Keywords: genetics, pharmacogenetics, ALS, Alzheimer, RNA-seq, next generation sequencing.



Dr. Jose Manuel Vidal Taboada

josevidal (at)